Skip to content

management of immature cataract (timira) with triphaladi compound and elaneer kuzhambu anjana

Further clinical study on evaluation of anti-cataract effect of Triphaladi Compound and Elaneer Kuzhambu in immature cataract w.s.r. Timira

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/01/004357
Enrollment
40
Registered
2014-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having Senile Immature Cataract

Interventions

Intervention1: Triphaladi yoga: Group A â?? Patients in the group will receive only Triphaladi yoga internally during three months of study. Intervention2: Triphaladi yoga and Elaneer kuzhambu: Group

Sponsors

IPGT AND RA GAU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Men and women 20 in each arm who meet the diagnostic standards of Immature Cataract 2. aged 35- 60 years of age are included in this study.

Exclusion criteria

Exclusion criteria: Subjects who are suffering from- 1. congenital Cataract 2. mature and hyper mature Cataract 3. Glaucoma 4. Diabetic Retinopathy 5. Macular degeneration 6. Retinitis pigmentosa 7. whose RBS and Blood Pressure are not within normal limits 8. who are under steroid treatment & or any kind of Immunosuppressive therapy or 9. under any Cataract inducing medication are excluded from this study.

Design outcomes

Primary

MeasureTime frame
1. Review of aetiopathogenesis of Timira as well as in modern literature and to establish a correlation with Cataract. 2. To assess the efficacy of test drugs as anti-Cataract agents in the clinical trial. Timepoint: 1. Conceptual Study- Till June 2014 2. Clinical Study- Till March 2015

Secondary

MeasureTime frame
1. To compile all the information related to the test drugs Elaneer kuzhambu anjana and Triphaladi yoga.Timepoint: 1. Conceptual Study- Till June 2014 2. Clinical Study- Till March 2015

Countries

India

Contacts

Public ContactDr Hitesh Bhati

IPGT AND RA, G.A.U. JAMNAGAR

bhatrajma2008@gmail.com9428400759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026